Author/Creator: Strassheimer, F - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Strassheimer, F

1. OS06.2A Local immunotherapy of glioblastoma via AAV-mediated gene transfer of checkpoint inhibitors in combination with CAR-NK cells. (9th September 2021)

Authors:: Strecker, M I; Wlotzka, K; Strassheimer, F; Reul, J; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Buchholz, C J; Burger, M C
Journal:: Neuro-oncology
Issue:: Volume 23: Supplement 2 (2021)
Page Start:: ii8
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo. (9th September 2021)

Authors:: Strassheimer, F; Strecker, M I; Alekseeva, T; Macas, J; Demes, M C; Mildenberger, I C; Tonn, T; Wild, P J; Sevenich, L; Reiss, Y; Harter, P N; Plate, K H; Wels, W S; Steinbach, J P; Burger, M C
Journal:: Neuro-oncology
Issue:: Volume 23: Supplement 2 (2021)
Page Start:: ii15
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. P04.21 Combination therapy of CAR-NK cells and anti-PD-1 antibody displays potent efficacy against late-stage Glioblastoma and induces protective antitumor immunity. (19th September 2018)

Authors:: Strassheimer, F; Zhang, C; Mildenberger, I C; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Burger, M C
Journal:: Neuro-oncology
Issue:: Volume 20(2018)Supplement 3
Page Start:: iii283
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. P06.12 Combination therapy of CAR-NK-cells and anti-PD-1 antibody results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo. (1st October 2020)

Authors:: Strassheimer, F; Strecker, MI; Alekseeva, T; Macas, J; Demes, MC; Mildenberger, IC; Tonn, T; Wild, PJ; Sevenich, L; Reiss, Y; Harter, PN; Plate, KH; Wels, WS; Steinbach, JP; Burger, MC
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8(2020)Supplement 2
Page Start:: A46
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. P06.13 A novel local treatment approach? Targeted immunotherapy of glioblastoma via AAV-mediated gene transfer of checkpoint inhibitors through locally administered HER2-AAVs in combination with CAR-NK cells. (1st October 2020)

Authors:: Strecker, MI; Strassheimer, F; Reul, J; Harter, PN; Tonn, T; Steinbach, JP; Wels, WS; Buchholz, CJ; Burger, MC
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8(2020)Supplement 2
Page Start:: A47
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. P12.04 Synergistic effects of combination therapy of CAR-NK cells and anti-PD-1 antibody result in high efficacy against advanced stage orthotopic glioblastoma grafts in a syngeneic mouse model and induce protective anti-tumor immunity in vivo. (6th September 2019)

Authors:: Strassheimer, F; Strecker, M I; Zhang, C; Mildenberger, I C; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Burger, M C
Journal:: Neuro-oncology
Issue:: Volume 21(2019)Supplement 3
Page Start:: iii60
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗